Toenail arsenic species and metallome profiles associated with breast, cervical, prostate, and skin cancer prevalence in the Atlantic Partnership for Tomorrow’s Health cohort

Posted on June 15, 2023June 15, 2023 by pathwp

Authors: Kalli Hood, Ellen Sweeney, Gabriela Ilie, Erin Keltie, Jong Sung Kim Journal: Frontiers in Public Health, Sec. Environmental Health and Exposome Abstract: Introduction: Chronic exposure to arsenic through drinking water has been linked to several cancers. The metabolism of arsenic is thought to play a key role in arsenic-related carcinogenesis as metabolites of varying toxicity Read more about Toenail arsenic species and metallome profiles associated with breast, cervical, prostate, and skin cancer prevalence in the Atlantic Partnership for Tomorrow’s Health cohort[…]

New Toxicology Publication

Posted on June 15, 2023June 15, 2023 by pathwp

Congratulations to Kalli Hood and team on their new publication in Frontiers in Public Health! Kalli’s Master’s research found an association between a history of cancer and arsenic speciation/metallome exposure in the Atlantic PATH cohort. This work is part of our larger focus on environment and cancer, and establishing toenails as an important biomarker representing Read more about New Toxicology Publication[…]

Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19

Posted on May 31, 2023 by pathwp

Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]

Mitacs Outstanding Entrepreneur Award

Posted on May 19, 2023November 28, 2023 by pathwp

Congratulations to our colleague, Dr. Rafaela Andrade, co-founder and CEO of Halifax-based company Myomar Molecular on their Mitacs Outstanding Entrepreneur Award!! Dr. Andrade has used Atlantic PATH data and biosamples in their project, Clinical Study and Identification of Muscle Atrophy Biomarkers. Dr. Andrade and Myomar Molecular’s work have developed the world’s first urine strip test for measuring Read more about Mitacs Outstanding Entrepreneur Award[…]

IWH Speaker Series

Posted on May 2, 2023 by pathwp

Many thanks to the Institute of Work and Health (IWH) for having Atlantic PATH Research Director, Dr. Ellen Sweeney at their Speaker Series today! IWH is a leader in work injury & disability prevention research. An independent, not-for-profit organization, IWH conducts and shares actionable research to promote, protect and improve the health and safety of Read more about IWH Speaker Series[…]

New Microbiome Publication

Posted on May 1, 2023May 1, 2023 by pathwp

Congratulations to our colleagues, Dr. Jacob Nearing, Dr. Vanessa DeClercq and Dr. Morgan Langille on their new microbiome publication!! “Investigating the Oral Microbiome in Retrospective and Prospective Cases of Prostate, Colon and Breast Cancer” utilizes saliva samples from Atlantic PATH and Alberta’s Tomorrow Project to consider potential biomarkers for cancer. Link to article in Nature Read more about New Microbiome Publication[…]

Changing the narrative of lung cancer to improve prevention for non-smokers

Posted on April 6, 2023April 11, 2023 by pathwp

Congratulations to Dr. Robin Urquhart and team on their successful funding from the Canadian Cancer Society to examine the effects of environmental exposures in non-smokers to detect lung cancer earlier. Lung cancer is most often linked to smoking, but can also occur in people who have never smoked because of exposure to arsenic, radon gas Read more about Changing the narrative of lung cancer to improve prevention for non-smokers[…]

The Ontario Public Health Convention (TOPHC)

Posted on March 27, 2023March 28, 2023 by pathwp

Dr. Ellen Sweeney (Research Director, Atlantic PATH) and Dr. Victoria Kirsh (Scientific Associate, Ontario Health Study) were pleased to attend the Ontario Public Health Convention (TOPHC) on behalf of CanPath. Dr. Sweeney presented on CanPath’s resources for research on chronic disease and cancer and Dr. Kirsh presented on risk factors for COVID-19 infection among CanPath Read more about The Ontario Public Health Convention (TOPHC)[…]

Webinar: Building the Canadian Cancer Society within CanPath

Posted on March 13, 2023 by pathwp

Join us on March 30th (1-2pm AST/12-1pm EST) for the CanPath webinar, “Building the Canadian Cancer Society within CanPath.” Registration: http://bit.ly/3JdYhCR About the webinar: Streams of big data are finally coming together to help us understand cancer and predict it earlier. CanPath is building the Canadian Cancer Study to advance research and discovery for cancer, Read more about Webinar: Building the Canadian Cancer Society within CanPath[…]